1986 | OriginalPaper | Buchkapitel
Pharmocology and Therapeutic Efficacy of Bleomycin Administered By Continuous Infusion
verfasst von : Irwin H. Krakoff
Erschienen in: Clinical Applications of Continuous Infusion Chemotherapy and Concomitant Radiation Therapy
Verlag: Springer US
Enthalten in: Professional Book Archive
Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.
Wählen Sie Textabschnitte aus um mit Künstlicher Intelligenz passenden Patente zu finden. powered by
Markieren Sie Textabschnitte, um KI-gestützt weitere passende Inhalte zu finden. powered by
Bleomycin was isolated by Umezawa1. It has been in clinical use for more than 15 years. The initial clinical studies performed by Ichikawa, et al2 demonstrated useful activity in the squamous carcinomas. Subsequent studies have demonstrated useful therapeutic activity in lymphomas and germ cell tumors3–5.